SSIIHealthcare · Medical DevicesThe 1 Wall Street analysts covering SS Innovations International, Inc. hold a median 12-month price target of $7 — +95.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 17 of 100 as at 22 Aug 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores SS Innovations International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (66): The business earns solid, repeatable profits on what it owns.
Volatility (13): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on SSII, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
The green dot is the last close — the median target sits +95.3% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 3 June 2026 | LUCID CAPITAL MARKETS | Initiates | Buy | $7.00 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SSII appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 99% of US stocks
Cheaper than 12% of US stocks
Cheaper than 8% of US stocks
Cheaper than 96% of US stocks
Higher than 83% of US stocks
Higher than 86% of US stocks
Higher than 60% of US stocks
Higher than 22% of US stocks
Higher than 15% of US stocks
Higher than 29% of US stocks
Higher than 30% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own SS Innovations International, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
SS Innovations International reported its second quarter 2026 financial results, posting record quarterly revenue. The revenue growth was driven by continued strong sales of its SSi Mantra surgical robotic units.
Why it matters — Record revenue and sustained growth in SSi Mantra unit sales signal strengthening commercial performance for SSII's core product offering.
The 1 Wall Street analysts covering SS Innovations International, Inc. have a median 12-month price target of $7, with estimates ranging from $7 to $7. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 1 analysts covering SS Innovations International, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SS Innovations International, Inc. 17 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Aug 2026, SS Innovations International, Inc. ranks 17 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (66 of 100).
No one can know that. What the data says: the median 12-month target from 1 analysts implies +95.3% from the last close, and Ticker Nerd's factor model ranks SS Innovations International, Inc. 17 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering SS Innovations International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SSII are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $7 to $7 over the next 12 months.
SS Innovations International, Inc. is a medical technology company specializing in the development and commercialization of advanced surgical robotic systems.
The most recent item we track (GlobeNewsWire, 13 Aug 2026): "SS Innovations Reports Second Quarter 2026 Financial Results". SS Innovations International reported its second quarter 2026 financial results, posting record quarterly revenue. The revenue growth was driven by continued strong sales of its SSi Mantra surgical robotic units.
SS Innovations International, Inc. is a medical technology company specializing in the development and commercialization of advanced surgical robotic systems. Founded in 2015 by Dr. Sudhir Srivastava, the company has positioned itself at the forefront of healthcare technology through its integration of proprietary software with artificial intelligence (AI) and deep learning, aiming to create autonomous, AI-enhanced robotic platforms. Its flagship product suite includes the SSi Mantra surgical robotic system, SSi Mudra endosurgical instruments, and a range of supporting technologies such as mixed and augmented reality training tools and automated surgical devices. Operating primarily within the health technology sector, SS Innovations focuses on making complex robotic-assisted procedures more accessible and affordable, particularly in underserved markets. The company’s innovations support a broad variety of surgical specialties and are distributed through both direct sales and international distributor networks, reflecting its global reach and ambition to decentralize surgical excellence. With its commitment to research and development, SS Innovations International, Inc. plays a significant role in advancing the adoption of robotics in modern medicine and transforming the standard of care in surgical environments.
CEO Dr. Sudhir Prem Srivastava M.D. · 483 employees · India · https://ssinnovations.com